Prevalence of tuberculosis notifications at a university hospital between 2010 and 2022
DOI:
https://doi.org/10.17058/reci.v15i3.20110Keywords:
Tuberculosis, Health Profile, Lost to Follow-Up, Tertiary Healthcare, Public Health SurveillanceAbstract
Background and Objectives: Tuberculosis remains a significant public health challenge. This study aimed to describe the sociodemographic and clinical-epidemiological profiles of tuberculosis cases and identify factors associated with loss to follow-up between 2010 and 2022 at a university hospital in São Paulo-SP, Brazil. Methods: This cross-sectional study analyzed secondary data from mandatory tuberculosis notifications in a tertiary health service in São Paulo. Descriptive statistics and measures of central tendency were applied. Poisson regression with robust variance was used to calculate prevalence ratios for loss to follow-up. Results: A total of 2,076 cases were reported during the study period, with 39% identified in urgent or emergency settings, and 10.6% classified as loss to follow-up. Higher prevalence of treatment discontinuation was associated with unemployment, diagnosis in urgent/emergency care or hospitalization, retreatment cases, alcohol use, and positive serology for human immunodeficiency virus. Conclusion: Many cases were reported in the urgent care and/or emergency sector, and treatment interruption was high. This scenario underscores the necessity for a comprehensive approach to tuberculosis, with a focus on cases diagnosed in tertiary care and those undergoing retreatment.
Downloads
References
1. World Health Organization (WHO). Global tuberculosis report 2024 [Internet]. Geneva: World Health Organization; 2024. https://www.who.int/publications/i/item/9789240101531
2. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância em Saúde. Manual de recomendações para o controle da tuberculose no Brasil. 2ª ed. atualizada. Brasília: Ministério da Saúde; 2019.
3. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Departamento de HIV/Aids, Tuberculose, Hepatites Virais e Infecções Sexualmente Transmissíveis. Boletim Epidemiológico: Tuberculose, 2024. Brasília: Ministério da Saúde; n. especial, 2024.
4. Perrechi MCT, Ribeiro SA. Outcomes of tuberculosis treatment among inpatients and outpatients in the city of São Paulo, Brazil. J bras pneumol 2011 Nov;37(6):783-90. https://doi.org/10.1590/S1806-37132011000600012
5. Paula R, Lefevre F, Lefevre AMC, et al. Why do tuberculosis patients look for urgency and emergency unities for diagnosis: a study on social representation. Rev bras epidemiol 2014 Jul;17(3):600-14. https://doi.org/10.1590/1809-4503201400030003
6. Ranzani OT, Rodrigues LC, Waldman EA, et al. Who are the patients with tuberculosis who are diagnosed in emergency facilities? An analysis of treatment outcomes in the state of São Paulo, Brazil. J bras pneumol 2018 Mar;44(2):125-33. https://doi.org/10.1590/S1806-37562017000000384
7. Prefeitura de São Paulo. Programa Municipal de Controle da Tuberculose. Boletim Epidemiológico da Tuberculose da Cidade de São Paulo 2023. São Paulo; 2023. https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/Boletim_Epidemiologico_TB_Cidade_SP_2023.pdf
8. Hino P, Yamamoto TT, Magnabosco GT, et al. Impact of COVID-19 on the control and reorganization of tuberculosis care. Acta Paul Enferm 2021;34:eAPE002115. https://doi.org/10.37689/acta-ape/2021AR02115
9. Ruiz-Bastián M, Díaz-Pollán B, Falces-Romero I, et al. Impact on tuberculosis diagnostic during COVID-19 pandemic in a tertiary care hospital. Enferm Infecc Microbiol Clin 2022 Mar;42(3):135-139. https://doi.org/10.1016/j.eimc.2022.11.002
10. United Nations. The Sustainable Development Goals report: special edition. New York: United Nations; special edition, 2023. https://unstats.un.org/sdgs/report/2023/The-Sustainable-Development-Goals-Report-2023.pdf
11. Thomé HR, Salamanca MAB, Andrade SM. Características clínicas, epidemiológicas e georreferenciamento da tuberculose em um centro de referência do Oeste do Paraná. Rev Saúde Pública Paraná 2020 Jul;3(1):86-96. https://doi.org/10.32811/25954482-2020v3n1p86
12. Ferreira MRL, Bonfim RO, Siqueira TC, et al. Abandonment of tuberculosis treatment: an integrative review. Rev Enferm Contemp 2018 Jul;7(1):63-71. https://doi.org/10.17267/2317-3378rec.v7i1.1579
13. Cola JP, Pinto SA, Souza JS, et al. Factors associated with abandonment of tuberculosis treatment: a cross-sectional study between 2014 and 2019. J Hum Growth Dev 2024 Jul;34(2):286-295. https://doi.org/10.36311/jhgd.v34.14098
14. Lucena LA de, Dantas GB da S, Carneiro TV, Lacerda HG. Factors Associated with the Abandonment of Tuberculosis Treatment in Brazil: A Systematic Review. Rev Soc Bras Med Trop 2023;56:e0155-2022. https://doi.org/10.1590/0037-8682-0155-2022
15. Bertolozzi MR, Takahashi RF, França FOS, et al. The incidence of tuberculosis and its relation to social inequalities: Integrative Review Study on PubMed Base. Esc Anna Nery 2020;24(1):e20180367. https://doi.org/10.1590/2177-9465-EAN-2018-0367
16. San Pedro A, Oliveira RM. Tuberculose e indicadores socioeconômicos: revisão sistemática da literatura. Rev Panam Salud Publica 2013;33(4):294-301. https://iris.paho.org/handle/10665.2/9185
17. Tomberg JO, Spagnolo LDML, Härter J, et al. Search behavior for health services for the detection of tuberculosis. Rev Enferm UFSM 2020 Jun;10:e52-e52. https://doi.org/10.5902/2179769241815
18. Terra AA, Silva GA, Silva MR, et al. Magnitude between accessibility, time period, and tuberculosis diagnosis. Acta Paul Enferm 2022;35:eAPE02692. http://dx.doi.org/10.37689/acta-ape/2022AO02692
19. Barreto-Duarte B, Villalva-Serra K, Miguez-Pinto JP, et al. Retreatment and Anti-tuberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study. Open Forum Infect Dis 2024 Aug;11(8):ofae416. https://doi.org/10.1093/ofid/ofae416
20. Wigger GW, Bouton TC, Jacobson KR, et al. The impact of alcohol use disorder on tuberculosis: a review of the epidemiology and potential immunologic mechanisms. Front immunol 2022 Mar;13:864817. https://doi.org/10.3389/fimmu.2022.864817
21. Kaliner E, Bornstein S, Kabha D, et al. A retrospective cohort analysis of treatment outcomes of patients with tuberculosis who used substances in Tel Aviv, Israel. Alcohol Alcohol, 2024 Mar;59(2):agad073. https://doi.org/10.1093/alcalc/agad073
22. Pinto PFPS, Santos BPS, Teixeira CSS, et al. Performance evaluation of tuberculosis control in Brazilian municipalities. Rev Saude Publica 2022 Jun;56:53. https://doi.org/10.11606/s1518-8787.2022056004020
23. Pereira AGL, Escosteguy CC, Gonçalves JB, et al. Factors associated with death from tuberculosis and treatment default in a General Hospital in the city of Rio de Janeiro, 2007 to 2014. Rev Epidemiol Controle Infecç 2018 Apr;8(2):150-158. https://doi.org/10.17058/reci.v8i2.10675
24. Bastos SH, Taminato M, Fernandes H, et al. Sociodemographic and health profile of TB/HIV co-infection in Brazil: a systematic review. Rev Bras Enferm 2019 Sep-Oct;72(5):1389-96. http://dx.doi.org/10.1590/0034-7167-2018-0285
25. Carvalho MV, Silva AR, Taminato M, et al. Tuberculosis/HIV coinfection focused on care and quality of life. Acta Paul Enferm 2022;35:eAPE02811. http://dx.doi.org/10.37689/acta-ape/2022AO02811
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Stephanie Ribeiro, Claudia Susana Pérez Guerrero, Suely Miyuki Yashiro, Nivia Aparecida Pissaia Sanches, Marina Doreto Castilho, Hugo Fernandes, Giselle Lima de Freitas, Meiry Fernanda Pinto Okuno, Paula Hino
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author must state that the paper is original (has not been published previously), not infringing any copyright or other ownership right involving third parties. Once the paper is submitted, the Journal reserves the right to make normative changes, such as spelling and grammar, in order to maintain the language standard, but respecting the author’s style. The published papers become ownership of RECI, considering that all the opinions expressed by the authors are their responsibility. Because we are an open access journal, we allow free use of articles in educational and scientific applications provided the source is cited under the Creative Commons CC-BY license.
